Fibrinolytic enhancement by stanozolol: a double blind trial.
D000328:Adult; D000368:Aged; D001777:Blood Coagulation / Q000187:drug effects*; D001780:Blood Coagulation Tests; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000517:prevention & control*; D004562:Electrocardiography; D005337:Fibrin; D005340:Fibrinogen; D005342:Fibrinolysis / Q000187:drug effects*; D005343:Fibrinolytic Agents / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000517:prevention & control; D010958:Plasminogen; D013197:Stanozolol / Q000627:therapeutic use*
D005343:Fibrinolytic Agents; D013197:Stanozolol; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen